-
Eli Lilly released new data from a study of its obesity drug Tirzepatide
On October 3, Eli Lilly presented the latest research data on Tirzepatide at the 59th Annual meeting of the European Association for the Study of Diabetes (EASD). The results showed that Tirzepatide ( ... -
Global weight loss drug leader to announce Q3 performance GLP-1 drug market potential is expected to continue to release
Global weight loss drug leader to announce Q3 performance GLP-1 drug market potential is expected to continue to release. On November 2nd, American weight loss drug leader Novo Nordisk will announce ... -
The global industrialization base for small molecule innovative drugs in Baiji Shenzhou has been launched
"Suzhou Industrial Park Released" WeChat official account news, on November 16, the global industrialization base of small molecule innovative drugs in Baekje China, located in Suzhou Industrial Park ... -
The United States is investigating the role of Meta Platforms in the illegal sale of drugs
According to The Wall Street Journal, the United States is investigating the role of Meta Platforms in the illegal sale of drugs. -
The United States is reportedly investigating the role of Meta in illegal drug sales
On March 18th, according to relevant documents and insiders, US authorities are investigating the role of Meta in illegal drug sales. US prosecutors in Virginia have issued subpoenas. The prosecutor ... -
The era of generic weight loss drugs is approaching, and the first batch of patents for GLP drugs have expired, leading to a fierce competition among competitors
The global weight loss drug market is currently divided into two parts. Novo Nordisk's Wegovy and Ozempic, as well as Eli Lilly's Zepbound and Mounjaro, are the most sought after and effective drugs ... -
323 drugs in the US are urgently needed due to the "drug shortage" raid!
The most severe "drug shortage" in history struck the United States. According to the latest data from the American Society of Health System Pharmacists (ASHP) and the Utah Center for Drug Informatio ... -
A milestone breakthrough! Google DeepMind launches a new generation of drug development AI model AlphaFold 3
On Wednesday Eastern Time, Google DeepMind released a new generation of AlphaFold 3 models for predicting protein structure, which can help scientists more accurately target disease mechanisms and de ... -
European drug regulatory agency recommends approval of Dupixen for the treatment of patients with chronic obstructive pulmonary disease
On May 31st local time, Sanofi and Regenerative announced that the European Medicines Agency's Committee on Medicines for Human Use (CHMP) has adopted a positive opinion recommending the approval of ... -
Eisai/Bojian Alzheimer's disease drug rejected by the European Union, and Eli Lilly monoclonal antibody may be affected
New Beijing News (Reporter Zhang Zhaohui) Recently, the Medicines Committee of the European Medicines Agency stated that it does not recommend the marketing authorization application for the Alzheime ... -
AstraZeneca's market value has surpassed £ 200 billion for the first time! The bold bet on anti-cancer drugs is yielding results
The market value of global pharmaceutical giant AstraZeneca broke through £ 200 billion ($257 billion) for the first time yesterday, after the company's bold bets on cancer drugs drove its stock pri ... -
Bristol Myers Squibb's original tumor treatment drug Abraxane has been officially launched in China
Bristol Myers Squibb's original tumor treatment drug Abraxane has been officially launched in China. On September 2nd, Bristol Myers Squibb China announced that the original tumor treatment drug Abra ... -
Lilly weight loss pills are now available for purchase on e-commerce platforms. Lilly China responds that they are self funded drugs
On December 25th, a reporter from The Paper noticed that several e-commerce platforms now offer diagnosis and treatment services for the Eli Lilly glucose dependent insulinotropic peptide (GIP)/gluca ...